Yourgene Health PLC
LSE:YGEN
Yourgene Health PLC
LSE:YGEN
Price:
0.515 GBX
Updated:
May 8, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of YGEN.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
YGEN
Relative Value
Base Case
Not Available
Valuation Multiples
Multiples Across Competitors
YGEN Competitors Multiples
Yourgene Health PLC Competitors
Yourgene Health PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Yourgene Health PLC
LSE:YGEN
|
16.4m GBP | 0.6 | -2 | -31.1 | -5.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
184.7B USD | 4.6 | 32.8 | 19.4 | 28.9 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
137.9B USD | 18.8 | 69.4 | 56.9 | 71.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
126.5B USD | 6 | 37.6 | 24.4 | 30.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.9B USD | 3.4 | 25.9 | 13.8 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
107.9B USD | 7.3 | 61.1 | 30.7 | 45.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.5B USD | 3.5 | 56.2 | 18.8 | 39.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
58.2B EUR | 2.7 | 38.3 | 18.4 | 31 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.7B USD | 8.4 | 36.5 | 26.5 | 28.7 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
51.5B USD | 13.6 | 80.6 | 60.3 | 78.5 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.6B CNY | 10.7 | 32.5 | 28.3 | 28.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
